•
Mar 31, 2024

Mineralys Therapeutics Q4 2024 Earnings Report

EPS
-$0.98
Previous year: -$0.61
+60.7%
Gross Profit
-$8K
0
Cash and Equivalents
$339M
Previous year: $239M
+41.6%
Free Cash Flow
-$19.2M
Previous year: -$29M
-33.8%
Total Assets
$347M
Previous year: $252M
+38.0%

Mineralys Therapeutics

Mineralys Therapeutics